Iberia Capital Upgrades Core Laboratories (CLB) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Core Lab Reports Q1 2015 EPS Of $0.86, Ex-Items; Record Q1 FCF Tops $72 Million; Share Count Falls Below 44 Million, A New 17-Year Low
April 22, 2015 4:29 PM EDTAMSTERDAM, April 22, 2015 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US")(Euronext Amsterdam: "CLB NA") reported first quarter 2015 earnings per diluted share ("EPS") of $0.86, excluding items ("ex-items") which are primarily employee severance costs and are referenced in the non-GAAP reconciliation included in this release. First quarter 2015 net income, ex-items, totaled $37,500,000, while revenue was $213,600,000, down 19% from first quarter 2014 levels. Year-over-year first quarter revenue was negatively affected by approximately $8,500,000, or 4%, in foreign currency exchange rate changes versus the U.S. dollar. Operating income, ex-items, was $50,700,000, yielding operating margins of 24%.
Free cash flow ("FCF"), defined as cash from operations... More
